711 related articles for article (PubMed ID: 29145972)
1. Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance.
Owyong M; Hosseini-Nassab N; Efe G; Honkala A; van den Bijgaart RJE; Plaks V; Smith BR
Drug Resist Updat; 2017 Nov; 33-35():23-35. PubMed ID: 29145972
[TBL] [Abstract][Full Text] [Related]
2. Immune Microenvironment of Brain Metastases-Are Microglia and Other Brain Macrophages Little Helpers?
You H; Baluszek S; Kaminska B
Front Immunol; 2019; 10():1941. PubMed ID: 31481958
[TBL] [Abstract][Full Text] [Related]
3. Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases.
Lim M; Puttick S; Houston ZH; Thurecht KJ; Kalita-de Croft P; Mahler S; Rose SE; Jeffree RL; Mazzieri R; Dolcetti R; Lakhani SR; Saunus JM
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875730
[TBL] [Abstract][Full Text] [Related]
4. Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
Cui X; Wang Q; Kang C
Front Immunol; 2021; 12():788733. PubMed ID: 34777399
[No Abstract] [Full Text] [Related]
5. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Mooradian MJ; Sullivan RJ
Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
[TBL] [Abstract][Full Text] [Related]
6. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
[TBL] [Abstract][Full Text] [Related]
7. The hubris and humility of cancer pharmacology in the post immuno-oncology era.
Lazo JS
Pharmacol Res Perspect; 2019 Dec; 7(6):e00527. PubMed ID: 31624635
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy targeting immune check-point(s) in brain metastases.
Di Giacomo AM; Valente M; Covre A; Danielli R; Maio M
Cytokine Growth Factor Rev; 2017 Aug; 36():33-38. PubMed ID: 28736183
[TBL] [Abstract][Full Text] [Related]
9. Diving into the mechanism of action of tumor immunotherapies with intravital imaging.
Bousso P
Immunol Rev; 2022 Mar; 306(1):218-223. PubMed ID: 34713901
[TBL] [Abstract][Full Text] [Related]
10. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the immune system in glioblastoma.
Brown NF; Carter TJ; Ottaviani D; Mulholland P
Br J Cancer; 2018 Nov; 119(10):1171-1181. PubMed ID: 30393372
[TBL] [Abstract][Full Text] [Related]
12. The current state of immunotherapy for primary and secondary brain tumors: similarities and differences.
Nejo T; Mende A; Okada H
Jpn J Clin Oncol; 2020 Oct; 50(11):1231-1245. PubMed ID: 32984905
[TBL] [Abstract][Full Text] [Related]
13. Supportive roles of brain macrophages in CNS metastases and assessment of new approaches targeting their functions.
You H; Baluszek S; Kaminska B
Theranostics; 2020; 10(7):2949-2964. PubMed ID: 32194848
[TBL] [Abstract][Full Text] [Related]
14. The inflammatory microenvironment in brain metastases: potential treatment target?
Berghoff AS; Preusser M
Chin Clin Oncol; 2015 Jun; 4(2):21. PubMed ID: 26112807
[TBL] [Abstract][Full Text] [Related]
15. Outlook: Immunotherapy in Gastrointestinal Carcinoma - Innovative Strategies.
Moehler M; Göpfert K; Lenz HJ
Oncol Res Treat; 2018; 41(5):313-315. PubMed ID: 29705792
[TBL] [Abstract][Full Text] [Related]
16. In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?
Aspeslagh S; Matias M; Palomar V; Dercle L; Lanoy E; Soria JC; Postel-Vinay S
Eur J Cancer; 2017 Dec; 87():65-74. PubMed ID: 29126088
[TBL] [Abstract][Full Text] [Related]
17. Intravital microscopy for real-time monitoring of drug delivery and nanobiological processes.
Momoh J; Kapsokalyvas D; Vogt M; Hak S; Kiessling F; van Zandvoort M; Lammers T; Sofias AM
Adv Drug Deliv Rev; 2022 Oct; 189():114528. PubMed ID: 36067968
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for Brain Tumors.
Sampson JH; Maus MV; June CH
J Clin Oncol; 2017 Jul; 35(21):2450-2456. PubMed ID: 28640704
[TBL] [Abstract][Full Text] [Related]
19. Tracking the seed and tending the soil: evolving concepts in metastatic breast cancer.
Comen EA
Discov Med; 2012 Aug; 14(75):97-104. PubMed ID: 22935206
[TBL] [Abstract][Full Text] [Related]
20. Intravital imaging of the functions of immune cells in the tumor microenvironment during immunotherapy.
Peng X; Wang Y; Zhang J; Zhang Z; Qi S
Front Immunol; 2023; 14():1288273. PubMed ID: 38124754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
